As of 2025-09-15, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (21.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.16 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -134.2%.
The range of the Relative Valuation is (15.11) - (22.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 13.6x | 12.8x |
| Forward P/E multiples | 9.0x - 13.4x | 12.9x |
| Fair Price | (15.11) - (22.52) | (21.62) |
| Upside | -123.9% - -135.6% | -134.2% |
| Date | P/E |
| 2025-09-12 | -37.53 |
| 2025-09-11 | -38.06 |
| 2025-09-10 | -38.03 |
| 2025-09-09 | -38.27 |
| 2025-09-08 | -36.25 |
| 2025-09-05 | -36.39 |
| 2025-09-04 | -35.27 |
| 2025-09-03 | -35.95 |
| 2025-09-02 | -34.16 |
| 2025-08-29 | -25.34 |
| 2025-08-28 | -25.33 |
| 2025-08-27 | -25.40 |
| 2025-08-26 | -25.06 |
| 2025-08-25 | -24.85 |
| 2025-08-22 | -25.37 |
| 2025-08-21 | -25.69 |
| 2025-08-20 | -25.44 |
| 2025-08-19 | -25.24 |
| 2025-08-18 | -25.81 |
| 2025-08-15 | -26.02 |
| 2025-08-14 | -25.46 |
| 2025-08-13 | -25.61 |
| 2025-08-12 | -24.61 |
| 2025-08-11 | -24.27 |
| 2025-08-08 | -24.74 |
| 2025-08-07 | -24.39 |
| 2025-08-06 | -24.18 |
| 2025-08-05 | -25.58 |
| 2025-08-04 | -25.82 |
| 2025-08-01 | -25.57 |
| 2025-07-31 | -25.54 |
| 2025-07-30 | -25.77 |
| 2025-07-29 | -24.65 |
| 2025-07-28 | -24.47 |
| 2025-07-25 | -25.10 |
| 2025-07-24 | -25.05 |
| 2025-07-23 | -25.18 |
| 2025-07-22 | -24.93 |
| 2025-07-21 | -24.69 |
| 2025-07-18 | -24.82 |
| 2025-07-17 | -25.06 |
| 2025-07-16 | -25.42 |
| 2025-07-15 | -24.96 |
| 2025-07-14 | -25.29 |
| 2025-07-11 | -24.80 |
| 2025-07-10 | -25.18 |
| 2025-07-09 | -25.45 |
| 2025-07-08 | -24.57 |
| 2025-07-07 | -24.83 |
| 2025-07-03 | -25.55 |